Press Releases

11/30/2011

Silicon Biosystems Announces Sale to Baylor College of Medicine

Silicon Biosystems, Inc., a provider of specialized molecular and cellular biology technology, announced today that Baylor College of Medicine has agreed to purchase the company's DEPArray™ technology for use in research programs related to prenatal diagnostics and molecular oncology.


The decision to acquire the DEPArray™ technology at Baylor College of Medicine has been led by Dr. Arthur Beaudet, Chairman of the Department of Molecular and Human Genetics at Baylor.

application pdfSilicon Biosystems Announces Sale to Baylor College of Medicine

continue →

09/20/2011

Silicon Biosystems Announces Agreement with Fox Chase Cancer Center

Silicon Biosystems, Inc., announced today its entry with Fox Chase Cancer Center in Philadelphia, PA into an agreement for the company's DEPArray™ technology. Dr. Massimo Cristofanilli, Professor and Chairman of the Department of Medical Oncology, and his colleagues at Fox Chase Cancer Center will use DEPArray™ technology to advance understanding of micrometastatic disease and the genetic heterogeneity of cancers.

continue →

12/13/2010

Silicon Biosystems Forms U.S. Subsidiary

Silicon Biosystems, S.p.A., announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc., to be headquartered in San Diego, California. The newly formed business will focus on commercial operations and the development of the North American research and clinical diagnostics markets for the company’s DEPArray™ technology platform.

continue →
Ask Us a QuestionShare your DEPArray™ storySubscribe to newsletter